VOGX
NASD Vogenx, Inc.$14.53 ↑ +0.00 (+0.00%) Trading Up from the previous close of $14.53, $1.48 below the day’s high of $16.01
- YTD change
- +11.77%
- vs 20-day SMA
- -30.90%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+3.05 (+23.46%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 62.2% away from all-time highs of $38.41
- VOGX is up 12% since the beginning of the year
- VOGX is up 12% over the past 12 months
- VOGX is down 57% over the past 1 month
- 0% of all VOGX investors are betting against VOGX
VOGX reads poor: the 12-month move is +23.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.18
- Last 5 days
- -16.92%
- vs 8-day SMA
- -13.03%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Vogenx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery and development of treatments for serious metabolic and gastrointestinal diseases. The company was founded by James Green, William Wilkison, and Steven Delmar on February 5, 2021 and is headquartered in Raleigh, NC.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.